Iris E. Allijn
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Electrospun Nanofibers in Biomedical Applications 3
- Co-authors
- Raymond M. Schiffelers (5 shared papers)Gert Storm (5 shared papers)Niels Willemen (3 shared papers)Shabir Hassan (3 shared papers)Jeroen Leijten (3 shared papers)Su Ryon Shin (3 shared papers)Jinghang Li (1 shared paper)Dimitrios Stamatialis (3 shared papers)
- Journals
- Membranes (2 papers)Advanced Healthcare Materials (2 papers)PLoS ONE (2 papers)International Journal of Pharmaceutics (1 paper)Biotechnology Letters (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Iris E. Allijn
12 papers receiving 383 citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 35
- Biomaterials 76
- Pharmacology 36
- Pharmacology 54
- Biomedical Engineering 124
Countries citing papers authored by Iris E. Allijn
This map shows the geographic impact of Iris E. Allijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris E. Allijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris E. Allijn more than expected).
Fields of papers citing papers by Iris E. Allijn
This network shows the impact of papers produced by Iris E. Allijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris E. Allijn. The network helps show where Iris E. Allijn may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris E. Allijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 114 | |
| 2 | 2021 | 79 | |
| 3 | 2016 | 30 | |
| 4 | 2016 | 29 | |
| 5 | 2016 | 27 | |
| 6 | 2019 | 24 | |
| 7 | 2020 | 22 | |
| 8 | 2022 | 18 | |
| 9 | 2017 | 13 | |
| 10 | 2019 | 11 | |
| 11 | 2018 | 11 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 0 |
About Iris E. Allijn
Iris E. Allijn is a scholar working on Molecular Biology, Biomaterials, Molecular Medicine, Biomedical Engineering and Surgery, having authored 13 papers that have together received 386 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (3 papers), Natural product bioactivities and synthesis (2 papers), 3D Printing in Biomedical Research (2 papers), Curcumin's Biomedical Applications (2 papers), Nanoplatforms for cancer theranostics (1 paper), Neuroscience and Neural Engineering (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Tissue Engineering and Regenerative Medicine (1 paper). The work is most often cited by research in Molecular Medicine (35 citations), Biomaterials (76 citations), Pharmacology (36 citations), Pharmacology (54 citations) and Biomedical Engineering (124 citations). Iris E. Allijn has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Raymond M. Schiffelers, Gert Storm, Niels Willemen, Shabir Hassan, Jeroen Leijten, Su Ryon Shin, Jinghang Li, Dimitrios Stamatialis, Josbert M. Metselaar and Jiong‐Wei Wang. Their work appears in journals such as Membranes, Advanced Healthcare Materials, PLoS ONE, International Journal of Pharmaceutics and Biotechnology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.